Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Announces Brokered LIFE Financing

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Oct 24, 2023 1:16am

188 Views

Post# 35697594

RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

If it is supposed to close that fast, they must have a buyer lined up already? If filled, the money woes are gone, no problem for a long while. That is good! The string of news releases did not get any moving value upwards, but perhaps the influx of money will. We all knew a raise was coming. Getting the GBM going would be sweet. Maybe more news worthy items are coming in the not so distant future

<< Previous

Bullboard Posts

Next >>

Mullen Group: Navigates market challenges towards success